HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Changes of nuclear matrix proteins during differentiation of human osteosarcoma MG-63 cells induced by HMBA].

Abstract
Human osteosarcoma MG-63 cells were induced into differentiation by hexamethylene bisacetamide (HMBA). Its nuclear matrix proteins were selectively extracted, and subjected to two dimensional gel electrophoresis analysis. The resulted protein patterns were analyzed by Melanie software. There were 12 spots changed remarkably during the differentiation induced by HMBA, nine of which were identified. The up-regulated proteins were identified as MHC class II antigen, interferon-stimulated gene factor 3d, hypothetical protein DKFZp434M2221.1,8-hydroxy-guanine glycosylase homolog ogg1, and vimentin. The down-regulated ones were hnRNP A2/B1 and actin; and two newly expressed proteins under induction were 60S ribosomal protein L21 and ST2 protein. This study suggests that the induced differentiation of carcinoma cells is accompanied with changes of nuclear matrix proteins, and confirms the presence of some specific nuclear matrix proteins associated with carcinoma cell growth and differentiation. The changed nuclear matrix proteins are potential markers for cancer diagnosis or targets for cancer therapy.
AuthorsChun Hong Zhao, Qi Fu Li, Zhi Xing Li, Jin An Chen
JournalFen zi xi bao sheng wu xue bao = Journal of molecular cell biology (Fen Zi Xi Bao Sheng Wu Xue Bao) Vol. 39 Issue 2 Pg. 169-76 (Apr 2006) ISSN: 1673-520X [Print] China
PMID16944589 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Acetamides
  • Antineoplastic Agents
  • Nuclear Matrix-Associated Proteins
  • hexamethylene bisacetamide
Topics
  • Acetamides (pharmacology)
  • Antineoplastic Agents (pharmacology)
  • Cell Differentiation (drug effects)
  • Cell Line, Tumor
  • Electrophoresis, Gel, Two-Dimensional
  • Humans
  • Nuclear Matrix-Associated Proteins (metabolism)
  • Osteosarcoma (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: